Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Love Ted W
Relationship:   Director
City:   Sunnyvale
State:   CA
   
Insider Summary:
  
   
Companies Owned :   10    
Direct Shares   252,099    

Indirect Shares

   0      
Direct Value   $2,545,173    

Indirect Value

   $0      
Total Shares   252,099      
Total Value   $2,545,173      


Nuvelo Inc $1,193 Onyx Pharmaceuticals Inc $0 Amicus Therapeutics Inc $1,389,910 Royalty Pharma Plc $974,873 Gilead Sciences Inc $179,197 Nuvelo Inc $1,193 Onyx Pharmaceuticals Inc $0 Amicus Therapeutics Inc $1,389,910 Royalty Pharma Plc $974,873 Gilead Sciences Inc $179,197
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Nuvelo Inc ABIO Director 2008-05-30 3,580 2004-02-27 0    Premium*  
            Onyx Pharmaceuticals Inc ONXX EVP, R&D and Tech. Ope... 2012-07-25 77,756 2010-02-01 0    Premium*  
            Santarus Inc SNTS Director 2014-01-02 0 2012-03-09 0    Premium*  
            Amicus Therapeutics Inc FOLD Director 2020-06-04 131,000 2014-03-12 0    Premium*  
            Global Blood Therapeutics, Inc. GBT President and CEO, Dir... 2022-10-05 0 2022-10-05 0    Premium*  
            Cascadian Therapeutics, Inc CASC Director 2018-03-09 0 2015-09-05 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2020-07-02 0 2019-09-18 0    Premium*  
            Royalty Pharma Plc RPRX Director 2023-06-23 36,941 0    Premium*  
            Seagen Inc SGEN 2023-12-14 0 2020-08-17 0    Premium*  
            Gilead Sciences Inc GILD Director 2024-05-08 2,822 2024-02-02 0    Premium*  
* Premium Members only  

Records found :    123         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CASC Cascadian Therapeutics, I... Director   –       •      –    2017-02-02 4 B $4.24 $97,520 D/D 23,000 27,209 2.39 -
ONXX Onyx Pharmaceuticals Inc EVP, R&D and Tech. Operations   •       –      –    2011-02-01 4 D $35.82 $75,688 D/D (2,113) 29,737 0 -
ONXX Onyx Pharmaceuticals Inc EVP, R&D and Tech. Operations   •       –      –    2012-02-01 4 D $41.98 $88,074 D/D (2,098) 56,804 0 -
ONXX Onyx Pharmaceuticals Inc EVP, R&D and Tech. Operations   •       –      –    2012-04-02 4 D $36.58 $27,689 D/D (757) 82,997 0 -
SNTS Santarus Inc Director   –       •      –    2014-01-02 4 D $32.00 $10,736,000 D/D (335,500) 0 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2015-09-05 4 D $3.25 $14,092 D/D (4,336) 13,005 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2016-06-06 5 D $7.38 $5,026 D/D (681) 27,209 0 -
GBT Global Blood Therapeutics... CEO and President   •       •      –    2016-07-01 4 D $3.40 $84,391 D/D (24,821) 1,139,815 0 -
GBT Global Blood Therapeutics... President and CEO   •       •      –    2016-07-01 4/A D $3.40 $84,391 D/D (24,821) 1,117,815 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2017-06-12 4 D $3.34 $1,794 D/D (537) 28,820 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2017-06-24 4 D $3.78 $8,562 D/D (2,265) 35,613 0 -
GBT Global Blood Therapeutics... See Remarks   •       •      –    2017-08-01 4 D $25.10 $113,778 D/D (4,533) 1,151,956 0 -
GBT Global Blood Therapeutics... See Remarks   •       •      –    2017-08-11 4 D $3.40 $421,340 D/D (124,106) 1,027,850 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2017-09-24 4 D $3.94 $2,340 D/D (594) 37,394 0 -
GBT Global Blood Therapeutics... See Remarks   •       •      –    2018-01-16 4 D $52.10 $890,024 D/D (17,083) 1,045,767 0 -
GBT Global Blood Therapeutics... See Remarks   •       •      –    2018-01-24 4 D $58.15 $1,009,135 D/D (17,354) 1,063,413 0 -
GBT Global Blood Therapeutics... See Remarks   •       •      –    2018-01-31 4 D $57.90 $1,004,739 D/D (17,353) 1,081,060 0 -
GBT Global Blood Therapeutics... See Remarks   •       •      –    2018-02-01 4 D $59.60 $356,468 D/D (5,981) 1,087,142 0 -
GBT Global Blood Therapeutics... See Remarks   •       •      –    2018-02-14 4 D $62.30 $1,081,092 D/D (17,353) 1,105,785 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2018-03-09 4 D $0.00 $0 D/D (37,394) 0 0 -
GBT Global Blood Therapeutics... See Remarks   •       •      –    2018-08-01 4 D $43.15 $466,710 D/D (10,816) 1,128,975 0 -
GBT Global Blood Therapeutics... See Remarks   •       •      –    2019-02-01 4 D $48.44 $378,510 D/D (7,814) 1,142,974 0 -
GBT Global Blood Therapeutics... See Remarks   •       •      –    2019-04-08 4 D $58.51 $1,015,383 D/D (17,354) 1,161,199 0 -
GBT Global Blood Therapeutics... See Remarks   •       •      –    2019-08-01 4 D $54.25 $889,375 D/D (16,394) 1,177,867 0 -
GBT Global Blood Therapeutics... See Remarks   •       •      –    2019-12-13 4 D $76.88 $3,335,285 D/D (43,383) 1,141,984 0 -
  123  Records found
  1   2   3  4   5      
  Page 3 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us